Trastuzumab News and Research

RSS
Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

Trastuzumab deruxtecan treatment maintains quality of life in HER2-low metastatic breast cancer patients

Trastuzumab deruxtecan treatment maintains quality of life in HER2-low metastatic breast cancer patients

Alternative approaches to functional and phenotypic assays using multi-parameter flow cytometry

Alternative approaches to functional and phenotypic assays using multi-parameter flow cytometry

Novel class of drug regresses active brain metastases in breast cancer patients

Novel class of drug regresses active brain metastases in breast cancer patients

Biodegradable, non-ionic polymeric nanovesicles efficiently encapsulate and deliver siRNA

Biodegradable, non-ionic polymeric nanovesicles efficiently encapsulate and deliver siRNA

'Crown-like structures' surrounding breast tumors could hinder treatment response, study finds

'Crown-like structures' surrounding breast tumors could hinder treatment response, study finds

Two Rutgers engineers create analytical tool to accelerate the production of biologic drugs

Two Rutgers engineers create analytical tool to accelerate the production of biologic drugs

Drugs targeting DNA damage response pathway show therapeutic potential against advanced solid tumors

Drugs targeting DNA damage response pathway show therapeutic potential against advanced solid tumors

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

Peptide-enhanced antibody therapy may help treat breast cancer metastasis to bone

Peptide-enhanced antibody therapy may help treat breast cancer metastasis to bone

Trastuzumab combined with trimodality treatment for HER2-overexpressing esophageal cancer found to be ineffective

Trastuzumab combined with trimodality treatment for HER2-overexpressing esophageal cancer found to be ineffective

MR-guided focused ultrasound can safely deliver antibody therapy to Her2-positive brain metastases

MR-guided focused ultrasound can safely deliver antibody therapy to Her2-positive brain metastases

New antibody conjugate delivers drugs to bone tumors and inhibits metastasis

New antibody conjugate delivers drugs to bone tumors and inhibits metastasis

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer

New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer

New technology tricks tumors to eliminate itself through the production of anti-cancer agents

New technology tricks tumors to eliminate itself through the production of anti-cancer agents

The Christie NHS Foundation Trust first to offer treatment in cancer patients’ homes

The Christie NHS Foundation Trust first to offer treatment in cancer patients’ homes

Cholesterol-lowering drugs may protect women's hearts from damage caused during chemotherapy

Cholesterol-lowering drugs may protect women's hearts from damage caused during chemotherapy

Statins may protect the heart from damaging side-effects of early breast cancer treatment

Statins may protect the heart from damaging side-effects of early breast cancer treatment

Researchers identify a potential target for small cell lung cancer

Researchers identify a potential target for small cell lung cancer